Upcoming ABBV earnings date and every past earnings report, with free AI analysis of each 10-K and 10-Q straight from SEC EDGAR filings.
No confirmed earnings date for ABBV in the next 90 days. Most companies report quarterly — AbbVie's last SEC filing was a 10-Q filed on May 8, 2026, so the next report typically follows roughly three months after. Check back closer to the expected window.
AbbVie delivered strong Q1 FY2026 revenue growth of 12.4% to $15.0B, but net income fell 46.0% to $695M, driven by elevated costs and below-the-line charges,…
AbbVie delivered strong FY2025 revenue growth of 8.6% to $61.2B, driven by its post-Humira portfolio, while net income dipped slightly to $4.2B amid heavy SG&A…
AbbVie's most recent earnings report was its Q1 FY2026 10-Q, filed with the SEC on May 8, 2026.
EarningsLens publishes free AI analysis of every ABBV 10-K and 10-Q filing. The latest covers Q1 FY2026 — open it from the report history on this page.
Like all U.S.-listed public companies, AbbVie reports four times a year: three quarterly 10-Q filings and one annual 10-K filing with the SEC.